Evidence map›Paper›PMID 40937571›Full record

ReviewInternational journal of molecular medicine2025

Role of the gut-brain axis in neurological diseases: Molecular connections and therapeutic implications (Review).

Hongjuan Zhang, Jia Luan, Ling He, Xianfang Pan, Hujun Zhang, Yujie Li, Haiyan Li

Abstract readReview
In one paragraph

Review in International journal of molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Frontiers in microbiology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongjuan Zhang *Department of Neurology, General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China.
Jia Luan *Health Examination Center, The 940th Hospital of The Joint Logistics Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730000, P.R. China.
Ling HeDepartment of Clinical Laboratory, The 940th Hospital of The Joint Logistics Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730070, P.R. China.
Xianfang PanDepartment of Neurology, General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China.
Hujun ZhangMinimally Invasive Department, Lanzhou Time Laser Plastic and Aesthetic Hospital, Lanzhou, Gansu 730000, P.R. China.
Yujie LiDepartment of Neurology, General Hospital of Western Theater Command, Chengdu, Sichuan 610083, P.R. China.
Haiyan LiDepartment of Blood Transfusion, The 940th Hospital of The Joint Logistics Support Force of The Chinese People's Liberation Army, Lanzhou, Gansu 730000, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gut-brain axis, a bidirectional communication system involving the central nervous system, enteric nervous system and gastrointestinal tract, plays a pivotal role in neurological health and disease. The present review synthesizes current evidence on its anatomical foundations, functional mechanisms and the role of gut microbiota in neurological diseases. It is explored how dysregulation of the gut-brain axis contributes to neurodegenerative, neuroinflammatory, neurodevelopmental, cerebrovascular and epileptic disorders through molecular mechanisms including neuroinflammation, neurotransmitter modulation, oxidative stress, and blood-brain barrier changes. Furthermore, therapeutic strategies targeting this axis, such as dietary interventions, probiotics, pharmacological approaches and emerging therapies were evaluated. The present review highlights the potential for developing biomarkers and personalized medicine approaches based on gut-brain axis components, while acknowledging translational challenges. However, significant heterogeneity in probiotic strains, FMT protocols, and patient microbiota baselines limits immediate translation. Future trials must address these variables through standardized designs and multi-omics biomarker integration.

Indexed as

BrainBrain-Gut AxisGastrointestinal MicrobiomeGastrointestinal TractNervous System DiseasesAnimalsBiomarkersHumansProbioticsBiomarkersblood-brain barriergut-brain axismolecular mechanisms; gut microbiotaneuroinflammationneurological diseasesneurotransmitter regulation

Identifiers

PMID40937571
PMCPMC12440273

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.